A large international panel of experts reviewed the evidence and agreed on how to define, classify, and treat hives (urticaria). They recommend starting with non-drowsy (second-generation) antihistamines, raising the dose if needed, and adding omalizumab for cases that do not respond. This guideline shapes how doctors treat hives worldwide.